Skip to main content
SpringerLink
Log in
Book cover

Infectious Diseases in Critical Care pp 567–580Cite as

Urinary Tract Infections

  • Chapter

  • 2129 Accesses

Abstract

Infection of the urinary tract (UTIs) represents one of the most commonly encountered disease processes in medicine. The spectrum of the illness severity is as wide as that of the patient population affected. In the US alone, urinary tract infections account for over seven million physician visits and require over 100,000 hospitalizations annually [1]. The financial burden of this is over 2 billion dollars per year, 500 million dollars of which is required to contend with nosocomial infections [1]. Of hospitalized patients, 3% develop an infection of the urinary tract, representing 40% of the 2 million nosocomial infections in the US annually [2]. Eighty percent of these infections occur in the setting of an indwelling urethral catheter, and in intensive care units (ICUs) up to 95% may be due to urinary catheterization [3–5]. Device-related infection rates (number of catheter-related UTIs per 1,000 catheter days) range from 9% to 18% in various ICUs worldwide [6–10]. Although the incidence of UTIs in the critically ill has been shown to vary based on the type of ICU, the impact in every unit is significant [6].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Foxman B, Brown P (2003) Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am 17(2):227–41

    PubMed  Google Scholar 

  2. Laupland KB, Zygun DA, Davies HD, Church DL, Louie TJ, Doig CJ (2002) Incidence and risk factors for acquiring nosocomial urinary tract infection in the critically ill. J Crit Care 17(1):50–7

    PubMed  Google Scholar 

  3. Sedor J, Mulholland SG (1999) Hospital-acquired urinary tract infections associated with the indwelling catheter. Urol Clin North Am 26(4):821–8

    CAS  PubMed  Google Scholar 

  4. Merle V, Germain JM, Bugel H, Nouvellon M, Lemeland JF, Czernichow P, Grise P (2002) Nosocomial urinary tract infections in urologic patients: assessment of a prospective surveillance program including 10,000 patients. Eur Urol 41(5):483–9

    PubMed  Google Scholar 

  5. Richards MJ, Edwards JR, Culver DH, Gaynes RP (1999) Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 27(5):887–92

    CAS  PubMed  Google Scholar 

  6. Emori TG, Banerjee SN, Culver DH, Gaynes RP, Horan TC, Edwards JR, Jarvis WR, Tolson JS (1991) Nosocomial infections in elderly patients in the United States, 1986–1990. National Nosocomial Infections Surveillance System. Am J Med 91(3B):289S–293S

    CAS  PubMed  Google Scholar 

  7. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274(8):639–44

    CAS  PubMed  Google Scholar 

  8. Zolldann D, Spitzer C, Hafner H, Waitschies B, Klein W, Sohr D, Block F, Lutticken R, Lemmen SW (2005) Surveillance of nosocomial infections in a neurologic intensive care unit. Infect Control Hosp Epidemiol 26(8):726–31

    PubMed  Google Scholar 

  9. Rosenthal VD, Guzman S, Crnich C (2004) Device-associated nosocomial infection rates in intensive care units of Argentina. Infect Control Hosp Epidemiol 25(3):251–5

    PubMed  Google Scholar 

  10. Trilla A (1994) Epidemiology of nosocomial infections in adult intensive care units. Intensive Care Med 20Suppl 3:S1–4

    PubMed  Google Scholar 

  11. Rosser CJ, Bare RL, Meredith JW (1999) Urinary tract infections in the critically ill patient with a urinary catheter. Am J Surg 177(4):287–90

    CAS  PubMed  Google Scholar 

  12. Platt R, Polk BF, Murdock B, Rosner B (1982)Mortality associated with nosocomial urinary-tract infection. N Engl J Med 307(11):637–42

    CAS  PubMed  Google Scholar 

  13. Hooton TM (2000) Pathogenesis of urinary tract infections: an update [review]. J Antimicrob Chemother 46Suppl 1:1–7; discussion 63–5

    CAS  Google Scholar 

  14. Ronald AR, Harding GK (1997) Complicated urinary tract infections. Infect Dis Clin North Am 11(3):583–92

    CAS  PubMed  Google Scholar 

  15. Melekos MD, Naber KG (2000) Complicated urinary tract infections [review]. Int J Antimicrob Agents 15(4):247–56

    CAS  PubMed  Google Scholar 

  16. Leone M, Albanese J, Garnier F, Sapin C, Barrau K, Bimar MC, Martin C (2003) Risk factors of nosocomial catheter-associated urinary tract infection in a polyvalent intensive care unit. Intensive Care Med 29(7):1077–80

    PubMed  Google Scholar 

  17. Turck M, Goffe B (1962) The urethral catheter and urinary tract infection. J Urol 88:834–7

    CAS  PubMed  Google Scholar 

  18. Shapiro M, Simchen E, Izraeli S, Sacks TG (1984) A multivariate analysis of risk factors for acquiring bacteriuria in patients with indwelling urinary catheters for longer than 24 hours. Infect Control 5(11):525–32

    CAS  PubMed  Google Scholar 

  19. Saint S, Lipsky BA (1999) Preventing catheter-related bacteriuria: should we? Can we? How? [Review] Arch Intern Med 159(8):800–8

    CAS  PubMed  Google Scholar 

  20. Sobel JD (1997) Pathogenesis of urinary tract infection. Role of host defenses. Infect Dis Clin North Am 11(3):531–49

    CAS  PubMed  Google Scholar 

  21. Carson C, Naber KG (2004) Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections. Drugs 64(12):1359–73

    CAS  PubMed  Google Scholar 

  22. Kahlmeter G; ECO.SENS (2003) An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 51(1):69–76

    CAS  PubMed  Google Scholar 

  23. Warren JW (2001) Catheter-associated urinary tract infections. Int J Antimicrob Agents 17(4):299–303

    CAS  PubMed  Google Scholar 

  24. Gordon KA, Jones RN; SENTRY Participant Groups (Europe, Latin America, North America) (2003) Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000). Diagn Microbiol Infect Dis 45(4):295–301

    CAS  PubMed  Google Scholar 

  25. Turnidge J, Bell J, Biedenbach DJ, Jones R (2002) Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Antimicrobial Surveillance Program, 1998–1999. Int J Antimicrob Agents 20(1):10–7

    CAS  PubMed  Google Scholar 

  26. Bouza E, San Juan R, Munoz P, Voss A, Kluytmans J (2001) A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004 study). European Study Group on Nosocomial Infection. Clin Microbiol Infect 7(10):532–42

    CAS  PubMed  Google Scholar 

  27. Wazait HD, Patel HR, Veer V, Kelsey M, Van Der Meulen JH, Miller RA, Emberton M (2003) Catheter-associated urinary tract infections: prevalence of uropathogens and pattern of antimicrobial resistance in a UK hospital (1996–2001). BJU Int 91(9):806–9

    CAS  PubMed  Google Scholar 

  28. Kahlmeter G (2003) Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study. Int J Antimicrob Agents 22Suppl 2:49–52

    PubMed  Google Scholar 

  29. Bochicchio GV, Joshi M, Shih D, Bochicchio K, Tracy K, Scalea TM (2003) Reclassification of urinary tract infections in critically ill trauma patients: a time-dependent analysis. Surg Infect (Larchmt) 4(4):379–85

    Google Scholar 

  30. Coker C, Poore CA, Li X, Mobley HL (2000) Pathogenesis of Proteus mirabilis urinary tract infection. Microbes Infect 2(12):1497–505

    CAS  PubMed  Google Scholar 

  31. Maki DG, Hennekens CG, Phillips CW, Shaw WV, Bennett JV (1973) Nosocomial urinary tract infection with Serratia marcescens: an epidemiologic study. J Infect Dis 128(5):579–87

    CAS  PubMed  Google Scholar 

  32. VanCouwenberghe CJ, Farver TB, Cohen SH (1997) Risk factors associated with isolation of Stenotrophomonas (Xanthomonas) maltophilia in clinical specimens. Infect Control Hosp Epidemiol 18(5):316–21

    CAS  PubMed  Google Scholar 

  33. Zolldann D, Spitzer C, Hafner H, Waitschies B, Klein W, Sohr D, Block F, Lutticken R, Lemmen SW (2005) Surveillance of nosocomial infections in a neurologic intensive care unit. Infect Control Hosp Epidemiol 26(8):726–31

    PubMed  Google Scholar 

  34. Leone M, Albanese J, Antonini F, Michel-Nguyen A, Blanc-Bimar MC, Martin C (2003) Long-term epidemiological survey of Candida species: comparison of isolates found in an intensive care unit and in conventional wards. J Hosp Infect 55(3):169–74

    CAS  PubMed  Google Scholar 

  35. Brauner A, Katouli M, Ostenson CG (1995) P-fimbriation and haemolysin production are the most important virulence factors in diabetic patients with Escherichia coli bacteraemia: a multivariate statistical analysis of seven bacterial virulence factors. J Infect 31(1):27–31

    CAS  PubMed  Google Scholar 

  36. Karkkainen UM, Ikaheimo R, Katila ML, Sivonen A, Siitonen A (2000) Low virulence of Escherichia coli strains causing urinary tract infection in renal disease patients. Eur J Clin Microbiol Infect Dis 19(4):254–9

    CAS  PubMed  Google Scholar 

  37. Hooton TM, Johnson C, Winter C, Kuwamura L, Rogers ME, Roberts PL, Stamm WE (1991) Single-dose and three-day regimens of ofloxacin versus trimethoprim-sulfamethoxazole for acute cystitis in women. Antimicrob Agents Chemother 35(7):1479–83

    CAS  PubMed  Google Scholar 

  38. Thulesius O, Araj G (1987) The effect of uropathogenic bacteria on ureteral motility. Urol Res 15(5):273–6

    CAS  PubMed  Google Scholar 

  39. Tambyah PA, Halvorson KT, Maki DG (1999) A prospective study of pathogenesis of catheter-associated urinary tract infections. Mayo Clin Proc 74(2):131–6

    CAS  PubMed  Google Scholar 

  40. Daifuku R, Stamm WE (1984) Association of rectal and urethral colonization with urinary tract infection in patients with indwelling catheters. JAMA 252(15):2028–30

    CAS  PubMed  Google Scholar 

  41. Stamm WE, Hooton TM, Johnson JR, Johnson C, Stapleton A, Roberts PL, Moseley SL, Fihn SD (1989) Urinary tract infections: from pathogenesis to treatment. J Infect Dis 159(3):400–6

    CAS  PubMed  Google Scholar 

  42. Matsukawa M, Kunishima Y, Takahashi S, Takeyama K, Tsukamoto T (2005) Bacterial colonization on intraluminal surface of urethral catheter. Urology 65(3):440–4

    PubMed  Google Scholar 

  43. Watnick P, Kolter R (2000) Biofilm, city of microbes. J Bacteriol 182(10):2675–9

    CAS  PubMed  Google Scholar 

  44. Brook I (2004) Urinary tract and genito-urinary suppurative infections due to anaerobic bacteria. Int J Urol 11(3):133–41

    PubMed  Google Scholar 

  45. Measley RE Jr, Levison ME (1991) Host defense mechanisms in the pathogenesis of urinary tract infection. Med Clin North Am 75(2):275–86

    PubMed  Google Scholar 

  46. Bechtold RE, Dyer RB, Zagoria RJ, Chen MY (1996) The perirenal space: relationship of pathologic processes to normal retroperitoneal anatomy. Radiographics 16(4):841–54

    CAS  PubMed  Google Scholar 

  47. Hinman F Jr, Cox CE (1966) The voiding vesical defense mechanism: the mathematical effect of residual urine, voiding interval and volume on bacteriuria. J Urol 96(4):491–8

    PubMed  Google Scholar 

  48. Kaye D (1968) Antibacterial activity of human urine. J Clin Invest 47(10):2374–9

    CAS  PubMed  Google Scholar 

  49. Patterson JE, Andriole VT (1997) Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am 11(3):735–50

    CAS  PubMed  Google Scholar 

  50. Mulholland SG (1979) Lower urinary tract antibacterial defense mechanisms. Invest Urol 17(2):93–7

    CAS  PubMed  Google Scholar 

  51. Toma G, Bates JM Jr, Kumar S (1994) Uromodulin (Tamm-Horsfall protein) is a leukocyte adhesion molecule. Biochem Biophys Res Commun 200(1):275–82

    CAS  PubMed  Google Scholar 

  52. Orskov I, Ferencz A, Orskov F (1980) Tamm-Horsfall protein or uromucoid is the normal urinary slime that traps type 1 fimbriated Escherichia coli. Lancet 1(8173):887

    CAS  PubMed  Google Scholar 

  53. Abrink M, Larsson E, Gobl A, Hellman L (2000) Expression of lactoferrin in the kidney: implications for innate immunity and iron metabolism. Kidney Int 57(5):2004–10

    CAS  PubMed  Google Scholar 

  54. Jin T, Bokarewa M, Tarkowski A (2005) The role of urokinase in innate immunity against Staphylococcus aureus. Microbes Infect 7(9–10):1170–5

    CAS  PubMed  Google Scholar 

  55. Jost SP, Gosling JA, Dixon JS (1989) The morphology of normal human bladder urothelium. J Anat 167:103–15

    CAS  PubMed  Google Scholar 

  56. Bower JM, Eto DS, Mulvey MA (2005) Covert operations of uropathogenic Escherichia coli within the urinary tract. Traffic 6(1):18–31

    CAS  PubMed  Google Scholar 

  57. Benson M, Jodal U, Agace W, Hellstrom M, Marild S, Rosberg S, Sjostrom M, Wettergren B, Jonsson S, Svanborg C (1996) Interleukin (IL)-6 and IL-8 in children with febrile urinary tract infection and asymptomatic bacteriuria. J Infect Dis 174(5):1080–4

    CAS  PubMed  Google Scholar 

  58. Lin SJ, Huang JL (1998) Circulating interleukin (IL)-1 beta, IL-6 and tumor necrosis factor-alpha in children with febrile infection — a comparison with C-reactive protein. Asian Pac J Allergy Immunol 16(2–3):105–9

    CAS  PubMed  Google Scholar 

  59. Otto G, Braconier J, Andreasson A, Svanborg C (1999) Interleukin-6 and disease severity in patients with bacteremic and nonbacteremic febrile urinary tract infection. J Infect Dis 179(1):172–9

    CAS  PubMed  Google Scholar 

  60. Mattsby-Baltzer I, Claesson I, Hanson LA, Jodal U, Kaijser B, Lindberg U, Peterson H (1981) Antibodies to lipid A during urinary tract infection. J Infect Dis 144(4):319–28

    CAS  PubMed  Google Scholar 

  61. Tolkoff-Rubin NE, Rubin RH (1997) Urinary tract infection in the immunocompromised host. Lessons from kidney transplantation and the AIDS epidemic. Infect Dis Clin North Am 11(3):707–17

    CAS  PubMed  Google Scholar 

  62. Raz R, Stamm WE (1993) A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 329(11):753–6

    CAS  PubMed  Google Scholar 

  63. Hooton TM, Scholes D, Hughes JP, Winter C, Roberts PL, Stapleton AE, Stergachis A, Stamm WE (1996) A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 335(7):468–74

    CAS  PubMed  Google Scholar 

  64. Gaffney RA, Schaeffer AJ, Anderson BE, Duncan JL (1994) Effect of Lewis blood group antigen expression on bacterial adherence to COS-1 cells. Infect Immun 62(7):3022–6

    CAS  PubMed  Google Scholar 

  65. Hinman F Jr, Cox CE (1967) Residual urine volume in normal male subjects. J Urol 97(4):641–5

    PubMed  Google Scholar 

  66. Fair WR, Parrish RF (1981) Antibacterial substances in prostatic fluid. Prog Clin Biol Res 75A:247–64

    CAS  PubMed  Google Scholar 

  67. Lipsky BA (1989) Urinary tract infections in men. Epidemiology, pathophysiology, diagnosis, and treatment. Ann Intern Med 110(2):138–50

    CAS  PubMed  Google Scholar 

  68. Johnson JR, Kuskowski MA, Gajewski A, Sahm DF, Karlowsky JA (2004) Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000–2001. J Infect Dis 190(10):1739–44

    CAS  PubMed  Google Scholar 

  69. Johnson JR, Lockman HA, Owens K, Jelacic S, Tarr PI (2003) High-frequency secondary mutations after suicide-driven allelic exchange mutagenesis in extraintestinal pathogenic Escherichia coli. J Bacteriol 185(17):5301–5. Erratum in: J Bacteriol 2003 185(22):6746

    CAS  PubMed  Google Scholar 

  70. Ofek I, Beachey EH (1980) Bacterial adherence. Adv Intern Med 25:503–32

    CAS  PubMed  Google Scholar 

  71. Le Bouguenec C (2005) Adhesins and invasins of pathogenic Escherichia coli. Int J Med Microbiol 295(6–7):471–8

    PubMed  Google Scholar 

  72. Gunther NW 4th, Lockatell V, Johnson DE, Mobley HL (2001) In vivo dynamics of type 1 fimbria regulation in uropathogenic Escherichia coli during experimental urinary tract infection. Infect Immun 69(5):2838–46

    CAS  PubMed  Google Scholar 

  73. Schembri MA, Klemm P (2001) Biofilm formation in a hydrodynamic environment by novel fimh variants and ramifications for virulence. Infect Immun 69(3):1322–8

    CAS  PubMed  Google Scholar 

  74. Foxman B, Zhang L, Tallman P, Palin K, Rode C, Bloch C, Gillespie B, Marrs CF (1995) Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection. J Infect Dis 172(6):1536–41

    CAS  PubMed  Google Scholar 

  75. Guignot J, Bernet-Camard MF, Pous C, Plancon L, Le Bouguenec C, Servin AL (2001) Polarized entry of uropathogenic Afa/Dr diffusely adhering Escherichia coli strain IH11128 into human epithelial cells: evidence for alpha5beta1 integrin recognition and subsequent internalization through a pathway involving caveolae and dynamic unstable microtubules. Infect Immun 69(3):1856–68

    CAS  PubMed  Google Scholar 

  76. Johnson JR (1991) Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 4(1):80–128

    CAS  PubMed  Google Scholar 

  77. Hultgren SJ, Schwan WR, Schaeffer AJ, Duncan JL (1986) Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli. Infect Immun 54(3):613–20

    CAS  PubMed  Google Scholar 

  78. Eisenstein BI (1981) Phase variation of type 1 fimbriae in Escherichia coli is under transcriptional control. Science 214(4518):337–9

    CAS  PubMed  Google Scholar 

  79. Funfstuck R, Tschape H, Stein G, Vollandt R, Schneider S (1989) Virulence of Escherichia coli strains in relation to their hemolysin formation, mannose-resistant hemagglutination, hydroxamate production, K 1-antigen and the plasmid profile in patients with chronic pyelonephritis. Clin Nephrol 32(4):178–84

    CAS  PubMed  Google Scholar 

  80. Funfstuck R, Stein G (1997) Pathogenetic aspects of urinary tract infection. Wien Med Wochenschr 147(19–20):465–9

    CAS  PubMed  Google Scholar 

  81. Mills M, Meysick KC, O’Brien AD (2000) Cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli kills cultured human uroepithelial 5637 cells by an apoptotic mechanism. Infect Immun 68(10):5869–80

    CAS  PubMed  Google Scholar 

  82. Loftus JC, Smith JW, Ginsberg MH (1994) Integrin-mediated cell adhesion: the extracellular face. J Biol Chem 269(41):25235–8

    CAS  PubMed  Google Scholar 

  83. Kaijser B, Ahlstedt S (1977) Protective capacity of antibodies against Escherichia coli and K antigens. Infect Immun 17(2):286–9

    CAS  PubMed  Google Scholar 

  84. Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, Kalbacher H, Nieuwenhuizen WF, Jung G, Tarkowski A, van Kessel KP, van Strijp JA (2001) Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med 193(9):1067–76

    CAS  PubMed  Google Scholar 

  85. Haley RW, Hooton TM, Culver DH, Stanley RC, Emori TG, Hardison CD, Quade D, Shachtman RH, Schaberg DR, Shah BV, Schatz GD (1981) Nosocomial infections in U.S. hospitals 1975–1976: estimated frequency by selected characteristics of patients. Am J Med 70(4):947–59

    CAS  PubMed  Google Scholar 

  86. Tambyah PA, Maki DG (2000) Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients. Arch Intern Med 160(5):678–82

    CAS  PubMed  Google Scholar 

  87. Nicolle LE (2005 Catheter-related urinary tract infection. Drugs Aging 22(8):627–39

    PubMed  Google Scholar 

  88. National Nosocomial Infections Surveillance (NNIS) (1998) System report, data summary from October 1986–April 1998, issued June 1998. Am J Infect Control 26(5):522–33

    Google Scholar 

  89. Stamm WE, Hooton TM (1993) Management of urinary tract infections in adults. N Engl J Med 329(18):1328–34

    CAS  PubMed  Google Scholar 

  90. Stark RP, Maki DG (1984) Bacteriuria in the catheterized patient. What quantitative level of bacteriuria is relevant? N Engl J Med 311(9):560–4

    Article  CAS  PubMed  Google Scholar 

  91. Grahn D, Norman DC, White ML, Cantrell M, Yoshikawa TT (1985) Validity of urinary catheter specimen for diagnosis of urinary tract infection in the elderly. Arch Intern Med 145(10):1858–60

    CAS  PubMed  Google Scholar 

  92. Tenney JH, Warren JW (1988) Bacteriuria in women with long-term catheters: paired comparison of indwelling and replacement catheters. J Infect Dis 157(1):199–202

    CAS  PubMed  Google Scholar 

  93. Soulen MC, Fishman EK, Goldman SM, Gatewood OM (1989) Bacterial renal infection: role of CT. Radiology 171(3):703–7

    CAS  PubMed  Google Scholar 

  94. Webb JA (1997) The role of imaging in adult acute urinary tract infection. Eur Radiol 7(6):837–43

    CAS  PubMed  Google Scholar 

  95. Lautin EM, Gordon PM, Friedman AC, Dourmashkin L, Fromowitz F (1979) Emphysematous pyelonephritis: optimal diagnosis and treatment. Urol Radiol 1(2):93–6

    CAS  PubMed  Google Scholar 

  96. Baumgarten DA, Baumgartner BR (1997) Imaging and radiologic management of upper urinary tract infections. Urol Clin North Am 24(3):545–69

    CAS  PubMed  Google Scholar 

  97. Ellenbogen PH, Scheible FW, Talner LB, Leopold GR (1978) Sensitivity of gray scale ultrasound in detecting urinary tract obstruction. AJR Am J Roentgenol 130(4):731–3

    CAS  PubMed  Google Scholar 

  98. Lee JK, Baron RL, Melson GL, McClennan BL, Weyman PJ (1981) Can real-time ultrasonography replace static Bscanning in the diagnosis of renal obstruction? Radiology 139(1):161–5

    CAS  PubMed  Google Scholar 

  99. Rusinek H, Kaur M, Lee VS (2004) Renal magnetic resonance imaging. Curr Opin Nephrol Hypertens 13(6):667–73

    PubMed  Google Scholar 

  100. Gold RP, McClennan BL, Rottenberg RR (1983) CT appearance of acute inflammatory disease of the renal interstitium. AJR Am J Roentgenol 141(2):343–9

    CAS  PubMed  Google Scholar 

  101. Kass EJ, Silver TM, Konnak JW, Thornbury JR, Wolfman MG (1976) The urographic findings in acute pyelonephritis: non-obstructive hydronephrosis. JUrol 116(5):544–6

    CAS  Google Scholar 

  102. Talner LB, Davidson AJ, Lebowitz RL, Dalla Palma L, Goldman SM (1994) Acute pyelonephritis: can we agree on terminology? Radiology 192(2):297–305

    CAS  PubMed  Google Scholar 

  103. Garibaldi RA, Burke JP, Dickman ML, Smith CB (1974) Factors predisposing to bacteriuria during indwelling urethral catheterization. N Engl J Med 291(5):215–9

    Article  CAS  PubMed  Google Scholar 

  104. Warren JW, Tenney JH, Hoopes JM, Muncie HL, Anthony WC (1982) A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis 146(6):719–23

    CAS  PubMed  Google Scholar 

  105. Alling B, Brandberg A, Seeberg S, Svanborg A (1975) Effect of consecutive antibacterial therapy on bacteriuria in hospitalized geriatric patients. Scand J Infect Dis 7(3):201–7

    CAS  PubMed  Google Scholar 

  106. Kauffman CA, Vazquez JA, Sobel JD, Gallis HA, McKinsey DS, Karchmer AW, Sugar AM, Sharkey PK, Wise GJ, Mangi R, Mosher A, Lee JY, Dismukes WE (2000) Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis 30(1):14–8

    CAS  PubMed  Google Scholar 

  107. Nicolle LE (2001) A practical guide to antimicrobial management of complicated urinary tract infection. Drugs Aging 18(4):243–5

    CAS  PubMed  Google Scholar 

  108. Wagenlehner FM, Weidner W, Naber KG (2005) Emergence of antibiotic resistance amongst hospital-acquired urinary tract infections and pharmacokinetic/pharmacodynamic considerations. J Hosp Infect 60(3):191–200

    CAS  PubMed  Google Scholar 

  109. Naber KG, Bergman B, Bishop MC, Bjerklund-Johansen TE, Botto H, Lobel B, Jinenez Cruz F, Selvaggi FP; Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU) (2001) EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol 40(5):576–88

    CAS  PubMed  Google Scholar 

  110. Jones RN, Beach ML, Pfaller MA (2001) Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): more alike than different! Diagn Microbiol Infect Dis 41(3):161–3

    CAS  PubMed  Google Scholar 

  111. Raz R, Schiller D, Nicolle LE (2000) Chronic indwelling catheter replacement before antimicrobial therapy for symptomatic urinary tract infection. J Urol 164(4):1254–8

    CAS  PubMed  Google Scholar 

  112. Gupta K, Hooton TM, Stamm WE (2001) Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 135(1):41–50

    CAS  PubMed  Google Scholar 

  113. Karlowsky JA, Draghi DC, Jones ME, Thornsberry C, Friedland IR, Sahm DF (2003) Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemother 47(5):1681–8

    CAS  PubMed  Google Scholar 

  114. Pfaller MA, Jones RN, Doern GV, Kugler K (1998) Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 42(7):1762–70

    CAS  PubMed  Google Scholar 

  115. Fung-Tomc JC, Gradelski E, Valera L, Kolek B, Bonner DP (2000) Comparative killing rates of fluoroquinolones and cell wall-active agents. Antimicrob Agents Chemother 44(5):1377–80

    CAS  PubMed  Google Scholar 

  116. Leone M, Garnier F, Avidan M, Martin C (2004) Catheter-associated urinary tract infections in intensive care units. Microbes Infect 6(11):1026–32

    PubMed  Google Scholar 

  117. Johnson JR, Roberts PL, Olsen RJ, Moyer KA, Stamm WE (1990) Prevention of catheter-associated urinary tract infection with a silver oxide-coated urinary catheter: clinical and microbiologic correlates. J Infect Dis 162(5):1145–50

    CAS  PubMed  Google Scholar 

  118. Riley DK, Classen DC, Stevens LE, Burke JP (1995) A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. Am J Med 98(4):349–56

    CAS  PubMed  Google Scholar 

  119. Schaeffer AJ, Story KO, Johnson SM (1988) Effect of silver oxide/trichloroisocyanuric acid antimicrobial urinary drainage system on catheter-associated bacteriuria. J Urol 139(1):69–73

    CAS  PubMed  Google Scholar 

  120. Liedberg H, Lundeberg T (1990) Silver alloy coated catheters reduce catheter-associated bacteriuria. Br J Urol 65(4):379–81

    CAS  PubMed  Google Scholar 

  121. Elmore JG, Sullivan SD, Emerson SS, Koepsell TD (1998) The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis. Am J Med 105(3):236–41

    PubMed  Google Scholar 

  122. Huth TS, Burke JP, Larsen RA, Classen DC, Stevens LE (1992) Randomized trial of meatal care with silver sulfadiazine cream for the prevention of catheter-associated bacteriuria. J Infect Dis 165(1):14–8

    CAS  PubMed  Google Scholar 

  123. Warren JW, Platt R, Thomas RJ, Rosner B, Kass EH (1978) Antibiotic irrigation and catheter-associated urinary-tract infections. N Engl J Med 299(11):570–3

    Article  CAS  PubMed  Google Scholar 

  124. Saint S, Lipsky BA (1999) Preventing catheter-related bacteriuria: should we? Can we? How? Arch Intern Med 1999 159(8):800–8

    CAS  PubMed  Google Scholar 

  125. Yen DH, Hu SC, Tsai J, Kao WF, Chern CH, Wang LM, Lee CH (1999) Renal abscess: early diagnosis and treatment. Am J Emerg Med 17(2):192–7

    CAS  PubMed  Google Scholar 

  126. Segura JW, Kelalis PP (1973) Localized renal parenchymal infections in children. J Urol 109(6):1029–32

    CAS  PubMed  Google Scholar 

  127. Klein DL, Filpi RG (1977) Acute renal carbuncle. J Urol 118(6):912–5

    CAS  PubMed  Google Scholar 

  128. Salvatierra O Jr, Bucklew WB, Morrow JW (1967) Perinephric abscess: a report of 71 cases. J Urol 98(3):296–302

    PubMed  Google Scholar 

  129. Schiff M Jr, Glickman M, Weiss RM, Ahern MJ, Touloukian RJ, Lytton B, Andriole VT (1977) Antibiotic treatment of renal carbuncle. Ann Intern Med 87(3):305–8

    PubMed  Google Scholar 

  130. Dembry LM, Andriole VT (1997) Renal and perirenal abscesses. Infect Dis Clin North Am 11(3):663–80

    CAS  PubMed  Google Scholar 

  131. Hoddick W, Jeffrey RB, Goldberg HI, Federle MP, Laing FC (1983) CT and sonography of severe renal and perirenal infections. AJR Am J Roentgenol 140(3):517–20

    CAS  PubMed  Google Scholar 

  132. Siegel JF, Smith A, Moldwin R (1996) Minimally invasive treatment of renal abscess. J Urol 155(1):52–5

    CAS  PubMed  Google Scholar 

  133. Saiki J, Vaziri ND, Barton C (1982) Perinephric and intranephric abscesses: a review of the literature. West J Med 136(2):95–102

    CAS  PubMed  Google Scholar 

  134. Thorley JD, Jones SR, Sanford JP (1974) Perinephric abscess. Medicine (Baltimore) 53(6):441–51

    CAS  Google Scholar 

  135. Edelstein H, McCabe RE (1988) Perinephric abscess. Modern diagnosis and treatment in 47 cases. Medicine (Baltimore) 67(2):118–31

    CAS  PubMed  Google Scholar 

  136. Hoddick W, Jeffrey RB, Goldberg HI, Federle MP, Laing FC (1983) CT and sonography of severe renal and perirenal infections. AJR Am J Roentgenol 140(3):517–20

    CAS  PubMed  Google Scholar 

  137. Michaeli J, Mogle P, Perlberg S, Heiman S, Caine M (1984) Emphysematous pyelonephritis. J Urol 131(2):203–8

    CAS  PubMed  Google Scholar 

  138. Evanoff GV, Thompson CS, Foley R, Weinman EJ (1987) Spectrum of gas within the kidney. Emphysematous pyelonephritis and emphysematous pyelitis. Am J Med 83(1):149–54

    CAS  PubMed  Google Scholar 

  139. Huang JJ, Chen KW, Ruaan MK, Tsai HM (1994) Recurrent emphysematous pyelonephritis. A case report. Int Urol Nephrol 26(4):389–93

    CAS  PubMed  Google Scholar 

  140. Cook DJ, Achong MR, Dobranowski J (1989) Emphysematous pyelonephritis. Complicated urinary tract infection in diabetes. Diabetes Care 12(3):229–32

    CAS  PubMed  Google Scholar 

  141. Flores G, Nellen H, Magana F, Calleja J (2002) Acute bilateral emphysematous pyelonephritis successfully managed by medical therapy alone: a case report and review of the literature. BMC Nephrol 3:4

    PubMed  Google Scholar 

  142. Stein JP, Spitz A, Elmajian DA, Esrig D, Freeman JA, Grossfeld GD, Ginsberg DA, Skinner DG (1996) Bilateral emphysematous pyelonephritis: a case report and review of the literature. Urology 47(1):129–34

    CAS  PubMed  Google Scholar 

  143. Hall JR, Choa RG, Wells IP (1988) Percutaneous drainage in emphysematous pyelonephritis — an alternative to major surgery. Clin Radiol 39(6):622–4

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Urologic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA

    D. McRackan MD & C. Carson MD

Authors
  1. D. McRackan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Carson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Critical Care Department, Joan XXIII University Hospital, Carrer Mallafré Guasch, 4, E-43007, Tarragona, Spain

    Jordi Rello MD, PhD  & Alejandro Rodríguez MD, PhD  & 

  2. Medical Intensive Care Unit, Washington University School of Medicine, Barnes-Jewish Hospital, 660 South Euclid Avenue, Campus Box 8052, St. Louis, MO, 63110-1093, USA

    Marin Kollef MD (Professor of Medicine and Director) (Professor of Medicine and Director)

  3. Intensive Care Department, Joan XXIII University Hospital, Carrer Mallafré Guasch, 4, E-43007, Tarragona, Spain

    Emili Díaz MD

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

McRackan, D., Carson, C. (2007). Urinary Tract Infections. In: Rello, J., Kollef, M., Díaz, E., Rodríguez, A. (eds) Infectious Diseases in Critical Care. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-34406-3_53

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-34406-3_53

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-34405-6

  • Online ISBN: 978-3-540-34406-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation